Adaptive Biotechnologies (ADPT) Tops Q4 EPS by 9c
Tweet
Share
E-mailGet Alerts ADPT Hot Sheet
Price: $21.02 -0.19%
Revenue Growth %: +11.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
CCEL, MHGU, PLG, More
Revenue Growth %: +11.7%
Financial Fact:
Basic (in Shares): -23.01M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Adaptive Biotechnologies (NASDAQ: ADPT) reported Q4 EPS of ($0.09), $0.09 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $71.7 million versus the consensus estimate of $59.33 million.
For earnings history and earnings-related data on Adaptive Biotechnologies (ADPT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Arrowhead Pharma (ARWR) at Buy
- Empire State Building launches family bundle with up to 20% off tickets
- Lode Gold plans $7M private placement with Coast Capital follow-on
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
